
Clinical Trials - January 7, 2015
Ebola Vaccine Trial Starts
An initiation of a Phase 1, first-in-human clinical trial of the preventative Ebola vaccine regimen consisting of MVA-BN® Filo and the AdVac® technology from Crucell Holland B.V., one of the Janssen Pharmaceutical Companies of Johnson & Johnson, took place recently, said Bavarian Nordic A/S. The first volunteers have received their initial vaccine dose and recruitment […]